Advertisement

Topics

Dissolution Technologies Company Profile

05:51 EST 13th December 2018 | BioPortfolio

This site is a companion to Dissolution Technologies, a quarterly publication reporting relevant information on dissolution testing. It provides an international forum for open exchange of information on various dissolution topics

Location

9 Yorkridge Trail
Hockessin
DE 19707
Germany

Contact

Phone: 302-235-0621.
Fax: 443-946-1264
Email: vgray@dissolutiontech.com


News Articles [248 Associated News Articles listed on BioPortfolio]

FDA's Final Guideline Standardizes Dissolution Testing For Highly Soluble Drugs

FDA guidance aims to establish uniform dissolution testing methods for highly soluble immediate-release solid oral dosage forms.    

The dissolution of temporal distance increases risk-taking: experimental evidence

Axim® Biotechnologies Announces Positive Results From Stability And Dissolution Tests On Medchew Rx Showing Greater Than 90% Availability

NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, today announced positive results from ...

Distek, Inc. launches new product that extends the capabilities of the symphony 7100

Distek, Inc. announced today the release of their small volume conversion kit for the symphony 7100 bathless dissolution tester,

The end of the Medical Council of India

India’s government delivered the final blow to the long suffering Medical Council of India (MCI) on 26 September 2018 with the promulgation of a presidential ordinance recommending its dissolution i...

Companies Reveal Likely EU Review Outcomes Against EMA Advice

The European Medicines Agency asks companies to wait until they know for certain whether their marketing authorization applications will be...    

Perrigo's OTC Core Could Expand To Include National Brands

Submitting an OTC switch of Nasonex would be a first for Perrigo, as would marketing a national brand OTC if...    

US FDA’s First Competitive Generic Therapy Approval Comes With A Twist

Apotex’s potassium chloride oral solution is eligible for 180-day exclusivity under new expedited pathway even though Amneal’s generic referencing same...   

PubMed Articles [557 Associated PubMed Articles listed on BioPortfolio]

Efficient CO Utilization via a Hybrid Na-CO System Based on CO Dissolution.

Carbon capture, utilization, and sequestration technologies have been extensively studied to utilize carbon dioxide (CO), a greenhouse gas, as a resource. So far, however, effective technologies have ...

Effects of Na+ and K+ Exchange in Interlayers on Biotite Dissolution under High Temperature and High CO2 Pressure Conditions.

Cations in formation brine can affect CO2-induced dissolution of minerals during geologic CO2 sequestration (GCS), affecting the GCS performance. This study investigated the dissolution of biotite wit...

Mechanistic Analysis Of Co-Crystal Dissolution, Surface Ph, And Dissolution Advantage As A Guide For Rational Selection.

The dissolution behavior of a dibasic drug ketoconazole (KTZ) under the influence of pH has been evaluated and compared to its three 1:1 co-crystals with diacidic coformers, fumaric acid (FUM), succin...

Dissolution or Disintegration - Substitution of Dissolution by Disintegration Testing for a Fixed Dose Combination Product.

According to ICH guideline Q6A, dissolution testing can be replaced by disintegration testing if it can be shown that the active pharmaceutical ingredient (API) is highly soluble and the formulation i...

Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine.

The oral cavity is of great importance to the performance of orally retained formulations, including: orally disintegrating tablets, taste-masked formulations, and buccal/sublingual delivery systems. ...

Clinical Trials [476 Associated Clinical Trials listed on BioPortfolio]

Shockwave Lithotripsy (SWL) Versus Oral Dissolution Therapy (ODT) Versus Combined SWL And ODT For Radiolucent Renal Stone

compare the efficacy of of ultrasound guided SWL versus dissolution therapy versus combined SWL and dissolution therapy in management of 1 - 2.5 cm renal stones.

Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self

The aim of the study is to identify neural signatures, behavioral and phenomenological expressions of self-related processes including: sense of agency, semantic distinction between self a...

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

This study will investigate the effect of Tafenoquine (TQ) 150 mg tablet ageing (dissolution profiles) on human exposure of TQ comparing the relative bioavailability of TQ from tablets exh...

Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis

The purpose of this study is to determine whether Renalof administration promotes partial or total dissolution of urinary calculi and improves physicochemical parameters and metabolic acti...

Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

Study to assess the relative Bioavailability To assess the relative bioavailability of three formulations of nifurtimox 30 mg tablets exhibiting different in vitro dissolution profiles To ...

Companies [1297 Associated Companies listed on BioPortfolio]

Dissolution Technologies

This site is a companion to Dissolution Technologies, a quarterly publication reporting relevant information on dissolution testing. It provides an international forum for open exchange of information...

Argonaut Technologies Inc

The Shareholders have voted for dissolution of the company. The vote was held and completed on March 21, 2011.

Distek, Inc.

In 2005, Distek will celebrate a 25 year tradition of quality and dependability by commemorating the release of our first dissolution tester, the Model 2000. Since our inception, Distek has retained ...

AuraZyme™ Pharmaceuticals

AuraZyme™ Pharmaceuticals is a development stage company founded to develop and commercialize therapeutic drug formulations that increase efficacy of drug therapy, lower drug dosage requirements, re...

pION Inc.

pION, a world leader in drug absorption measurement, specializes in the determination and prediction of solubility, dissolution, permeability and human absorption. pION also offers a range of instrume...

More Information about "Dissolution Technologies" on BioPortfolio

We have published hundreds of Dissolution Technologies news stories on BioPortfolio along with dozens of Dissolution Technologies Clinical Trials and PubMed Articles about Dissolution Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dissolution Technologies Companies in our database. You can also find out about relevant Dissolution Technologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record